{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:19:33Z","timestamp":1791166773007,"version":"4.1.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"37","license":[{"start":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T00:00:00Z","timestamp":1247443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T00:00:00Z","timestamp":1247443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2009,9,17]]},"DOI":"10.1038\/onc.2009.181","type":"journal-article","created":{"date-parts":[[2009,7,13]],"date-time":"2009-07-13T16:17:41Z","timestamp":1247501861000},"page":"3307-3319","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesis"],"prefix":"10.1038","volume":"28","author":[{"given":"H","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P A","family":"Humphrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Milbrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,7,13]]},"reference":[{"key":"BFonc2009181_CR1","doi-asserted-by":"publisher","first-page":"2410","DOI":"10.1101\/gad.819500","volume":"14","author":"C Abate-Shen","year":"2000","unstructured":"Abate-Shen C, Shen MM . (2000). Molecular genetics of prostate cancer. Genes Dev 14: 2410\u20132434.","journal-title":"Genes Dev"},{"key":"BFonc2009181_CR2","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1128\/MCB.22.5.1495-1503.2002","volume":"22","author":"SA Abdulkadir","year":"2002","unstructured":"Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA et al. (2002). Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol 22: 1495\u20131503.","journal-title":"Mol Cell Biol"},{"key":"BFonc2009181_CR3","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1158\/0008-5472.CAN-04-2688","volume":"65","author":"E Asatiani","year":"2005","unstructured":"Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR et al. (2005). Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Cancer Res 65: 1164\u20131173.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR4","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1158\/0008-5472.CAN-04-0020","volume":"64","author":"S Ashida","year":"2004","unstructured":"Ashida S, Nakagawa H, Katagiri T, Furihata M, Iiizumi M, Anazawa Y et al. (2004). Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res 64: 5963\u20135972.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR5","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/nature03626","volume":"435","author":"E Batlle","year":"2005","unstructured":"Batlle E, Bacani J, Begthel H, Jonkheer S, Gregorieff A, van de Born M et al. (2005). EphB receptor activity suppresses colorectal cancer progression. Nature 435: 1126\u20131130.","journal-title":"Nature"},{"key":"BFonc2009181_CR6","doi-asserted-by":"publisher","first-page":"1740","DOI":"10.1002\/pros.20579","volume":"67","author":"CR Bethel","year":"2007","unstructured":"Bethel CR, Bieberich CJ . (2007). Loss of Nkx3.1 expression in the transgenic adenocarcinoma of mouse prostate model. Prostate 67: 1740\u20131750.","journal-title":"Prostate"},{"key":"BFonc2009181_CR7","doi-asserted-by":"publisher","first-page":"10683","DOI":"10.1158\/0008-5472.CAN-06-0963","volume":"66","author":"CR Bethel","year":"2006","unstructured":"Bethel CR, Faith D, Li X, Guan B, Hicks JL, Lan F et al. (2006). Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Cancer Res 66: 10683\u201310690.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR8","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1101\/gad.13.8.966","volume":"13","author":"R Bhatia-Gaur","year":"1999","unstructured":"Bhatia-Gaur R, Donjacour AA, Sciavolino PJ, Kim M, Desai N, Young P et al. (1999). Roles for Nkx3.1 in prostate development and cancer. Genes Dev 13: 966\u2013977.","journal-title":"Genes Dev"},{"key":"BFonc2009181_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9","volume":"89","author":"DG Bostwick","year":"2000","unstructured":"Bostwick DG, Alexander EE, Singh R, Shan A, Qian J, Santella RM et al. (2000). Antioxidant enzyme expression and reactive oxygen species damage in prostatic intraepithelial neoplasia and cancer. Cancer 89: 123\u2013134.","journal-title":"Cancer"},{"key":"BFonc2009181_CR10","first-page":"3869","volume":"53","author":"GS Bova","year":"1993","unstructured":"Bova GS, Carter BS, Bussemakers MJ, Emi M, Fujiwara Y, Kyprianou N et al. (1993). Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. Cancer Res 53: 3869\u20133873.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR11","first-page":"6111","volume":"60","author":"C Bowen","year":"2000","unstructured":"Bowen C, Bubendorf L, Voeller HJ, Slack R, Willi N, Sauter G et al. (2000). Loss of NKX3.1 expression in human prostate cancers correlates with tumor progression. Cancer Res 60: 6111\u20136115.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR12","doi-asserted-by":"publisher","first-page":"8152","DOI":"10.1200\/JCO.2005.03.1492","volume":"23","author":"JM Chan","year":"2005","unstructured":"Chan JM, Gann PH, Giovannucci EL . (2005). Role of diet in prostate cancer development and progression. J Clin Oncol 23: 8152\u20138160.","journal-title":"J Clin Oncol"},{"key":"BFonc2009181_CR13","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","volume":"436","author":"Z Chen","year":"2005","unstructured":"Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M et al. (2005). Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725\u2013730.","journal-title":"Nature"},{"key":"BFonc2009181_CR14","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1242\/dev.120.5.1071","volume":"120","author":"SK Das","year":"1994","unstructured":"Das SK, Wang XN, Paria BC, Damm D, Abraham JA, Klagsbrun M et al. (1994). Heparin-binding EGF-like growth factor gene is induced in the mouse uterus temporally by the blastocyst solely at the site of its apposition: a possible ligand for interaction with blastocyst EGF-receptor in implantation. Development 120: 1071\u20131083.","journal-title":"Development"},{"key":"BFonc2009181_CR15","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/S0002-9440(10)65517-4","volume":"155","author":"AM De Marzo","year":"1999","unstructured":"De Marzo AM, Marchi VL, Epstein JI, Nelson WG . (1999). Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155: 1985\u20131992.","journal-title":"Am J Pathol"},{"key":"BFonc2009181_CR16","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/84879","volume":"27","author":"A Di Cristofano","year":"2001","unstructured":"Di Cristofano A, De Acetis M, Koff A, Cordon-Cardo C, Pandolfi PP . (2001). Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Nat Genet 27: 222\u2013224.","journal-title":"Nat Genet"},{"key":"BFonc2009181_CR17","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/S1525-1578(10)60645-9","volume":"3","author":"T Ehrig","year":"2001","unstructured":"Ehrig T, Abdulkadir SA, Dintzis SM, Milbrandt J, Watson MA . (2001). Quantitative amplification of genomic DNA from histological tissue sections after staining with nuclear dyes and laser capture microdissection. J Mol Diagn 3: 22\u201325.","journal-title":"J Mol Diagn"},{"key":"BFonc2009181_CR18","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","volume":"4","author":"K Ellwood-Yen","year":"2003","unstructured":"Ellwood-Yen K, Graeber TG, Wongvipat J, Iruela-Arispe ML, Zhang J, Matusik R et al. (2003). Myc-driven murine prostate cancer shares molecular features with human prostate tumors. Cancer Cell 4: 223\u2013238.","journal-title":"Cancer Cell"},{"key":"BFonc2009181_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1006\/scbi.2001.0422","volume":"12","author":"R Eshel","year":"2002","unstructured":"Eshel R, Neumark E, Sagi-Assif O, Witz IP . (2002). Receptors involved in microenvironment-driven molecular evolution of cancer cells. Semin Cancer Biol 12: 139\u2013147.","journal-title":"Semin Cancer Biol"},{"key":"BFonc2009181_CR20","doi-asserted-by":"publisher","first-page":"17204","DOI":"10.1073\/pnas.0407693101","volume":"101","author":"H Gao","year":"2004","unstructured":"Gao H, Ouyang X, Banach-Petrosky W, Borowsky AD, Lin Y, Kim M et al. (2004). A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci USA 101: 17204\u201317209.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009181_CR21","doi-asserted-by":"publisher","first-page":"15382","DOI":"10.1073\/pnas.95.26.15382","volume":"95","author":"EM Garabedian","year":"1998","unstructured":"Garabedian EM, Humphrey PA, Gordon JI . (1998). A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proc Natl Acad Sci USA 95: 15382\u201315387.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009181_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1007\/s00345-004-0474-0","volume":"23","author":"M Gleave","year":"2005","unstructured":"Gleave M, Miyake H . (2005). Use of antisense oligonucleotides targeting the cytoprotective gene, clusterin, to enhance androgen- and chemo-sensitivity in prostate cancer. World J Urol 23: 38\u201346.","journal-title":"World J Urol"},{"key":"BFonc2009181_CR23","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","volume":"92","author":"NM Greenberg","year":"1995","unstructured":"Greenberg NM, DeMayo F, Finegold MJ, Medina D, Tilley WD, Aspinall JO et al. (1995). Prostate cancer in a transgenic mouse. Proc Natl Acad Sci USA 92: 3439\u20133443.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009181_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1006\/geno.1997.4715","volume":"43","author":"WW He","year":"1997","unstructured":"He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS et al. (1997). A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. Genomics 43: 69\u201377.","journal-title":"Genomics"},{"key":"BFonc2009181_CR25","first-page":"2999","volume":"62","author":"MJ Kim","year":"2002","unstructured":"Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW et al. (2002). Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res 62: 2999\u20133004.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ccr.2006.03.031","volume":"9","author":"Q Lei","year":"2006","unstructured":"Lei Q, Jiao J, Xin L, Chang CJ, Wang S, Gao J et al. (2006). NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell 9: 367\u2013378.","journal-title":"Cancer Cell"},{"key":"BFonc2009181_CR27","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S1525-1578(10)60445-X","volume":"5","author":"V Luzzi","year":"2003","unstructured":"Luzzi V, Mahadevappa M, Raja R, Warrington JA, Watson MA . (2003). Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis. J Mol Diagn 5: 9\u201314.","journal-title":"J Mol Diagn"},{"key":"BFonc2009181_CR28","first-page":"5390","volume":"55","author":"JA Macoska","year":"1995","unstructured":"Macoska JA, Trybus TM, Benson PD, Sakr WA, Grignon DJ, Wojno KD et al. (1995). Evidence for three tumor suppressor gene loci on chromosome 8p in human prostate cancer. Cancer Res 55: 5390\u20135395.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/S1535-6108(03)00047-3","volume":"3","author":"JA Magee","year":"2003","unstructured":"Magee JA, Abdulkadir SA, Milbrandt J . (2003). Haploinsufficiency at the Nkx3.1 locus. A paradigm for stochastic, dosage-sensitive gene regulation during tumor initiation. Cancer Cell 3: 273\u2013283.","journal-title":"Cancer Cell"},{"key":"BFonc2009181_CR30","doi-asserted-by":"publisher","first-page":"7841","DOI":"10.1073\/pnas.1232229100","volume":"100","author":"PK Majumder","year":"2003","unstructured":"Majumder PK, Yeh JJ, George DJ, Febbo PG, Kum J, Xue Q et al. (2003). Prostate intraepithelial neoplasia induced by prostate restricted Akt activation: the MPAKT model. Proc Natl Acad Sci USA 100: 7841\u20137846.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009181_CR31","doi-asserted-by":"publisher","first-page":"6896","DOI":"10.1158\/0008-5472.CAN-08-0578","volume":"68","author":"MC Markowski","year":"2008","unstructured":"Markowski MC, Bowen C, Gelmann EP . (2008). Inflammatory cytokines induce phosphorylation and ubiquitination of prostate suppressor protein NKX3.1. Cancer Res 68: 6896\u20136901.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/j.1749-6632.2001.tb02734.x","volume":"952","author":"WG Nelson","year":"2001","unstructured":"Nelson WG, De Marzo AM, Deweese TL, Lin X, Brooks JD, Putzi MJ et al. (2001). Preneoplastic prostate lesions: an opportunity for prostate cancer prevention. Ann N Y Acad Sci 952: 135\u2013144.","journal-title":"Ann N Y Acad Sci"},{"key":"BFonc2009181_CR33","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1056\/NEJMra021562","volume":"349","author":"WG Nelson","year":"2003","unstructured":"Nelson WG, De Marzo AM, Isaacs WB . (2003). Prostate cancer. N Engl J Med 349: 366\u2013381.","journal-title":"N Engl J Med"},{"key":"BFonc2009181_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0002-9440(10)64857-2","volume":"160","author":"TD Oberley","year":"2002","unstructured":"Oberley TD . (2002). Oxidative damage and cancer. Am J Pathol 160: 403\u2013408.","journal-title":"Am J Pathol"},{"key":"BFonc2009181_CR35","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.1158\/0008-5472.CAN-05-1948","volume":"65","author":"X Ouyang","year":"2005","unstructured":"Ouyang X, DeWeese TL, Nelson WG, Abate-Shen C . (2005). Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. Cancer Res 65: 6773\u20136779.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR36","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1158\/0008-5472.CAN-07-6055","volume":"68","author":"X Ouyang","year":"2008","unstructured":"Ouyang X, Jessen WJ, Al-Ahmadie H, Serio AM, Lin Y, Shih WJ et al. (2008). Activator protein-1 transcription factors are associated with progression and recurrence of prostate cancer. Cancer Res 68: 2132\u20132144.","journal-title":"Cancer Res"},{"key":"BFonc2009181_CR37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/sj.cdd.4401779","volume":"13","author":"B Shannan","year":"2006","unstructured":"Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W et al. (2006). Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 13: 12\u201319.","journal-title":"Cell Death Differ"},{"key":"BFonc2009181_CR38","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1677\/erc.0.0100225","volume":"10","author":"J Simard","year":"2003","unstructured":"Simard J, Dumont M, Labuda D, Sinnett D, Meloche C, El-Alfy M et al. (2003). Prostate cancer susceptibility genes: lessons learned and challenges posed. Endocr Relat Cancer 10: 225\u2013259.","journal-title":"Endocr Relat Cancer"},{"key":"BFonc2009181_CR39","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1042\/BJ20051030","volume":"393","author":"SO Simmons","year":"2006","unstructured":"Simmons SO, Horowitz JM . (2006). Nkx3.1 binds and negatively regulates the transcriptional activity of Sp-family members in prostate-derived cells. Biochem J 393: 397\u2013409.","journal-title":"Biochem J"},{"key":"BFonc2009181_CR40","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1242\/dev.129.12.2879","volume":"129","author":"H Song","year":"2002","unstructured":"Song H, Lim H, Paria BC, Matsumoto H, Swift LL, Morrow J et al. (2002). Cytosolic phospholipase A2alpha is crucial [correction of A2alpha deficiency is crucial] for \u2018on-time\u2019 embryo implantation that directs subsequent development. Development 129: 2879\u20132889.","journal-title":"Development"},{"key":"BFonc2009181_CR41","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1093\/nar\/28.12.2389","volume":"28","author":"DJ Steadman","year":"2000","unstructured":"Steadman DJ, Giuffrida D, Gelmann EP . (2000). DNA-binding sequence of the human prostate-specific homeodomain protein NKX3.1. Nucleic Acids Res 28: 2389\u20132395.","journal-title":"Nucleic Acids Res"},{"key":"BFonc2009181_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0003-9861(02)00337-5","volume":"405","author":"C Thorpe","year":"2002","unstructured":"Thorpe C, Hoober KL, Raje S, Glynn NM, Burnside J, Turi GK et al. (2002). Sulfhydryl oxidases: emerging catalysts of protein disulfide bond formation in eukaryotes. Arch Biochem Biophys 405: 1\u201312.","journal-title":"Arch Biochem Biophys"},{"key":"BFonc2009181_CR43","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1126\/science.1117679","volume":"310","author":"SA Tomlins","year":"2005","unstructured":"Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW et al. (2005). Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310: 644\u2013648.","journal-title":"Science"},{"key":"BFonc2009181_CR44","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1158\/1078-0432.CCR-03-0200","volume":"10","author":"JV Tricoli","year":"2004","unstructured":"Tricoli JV, Schoenfeldt M, Conley BA . (2004). Detection of prostate cancer and predicting progression: current and future diagnostic markers. Clin Cancer Res 10: 3943\u20133953.","journal-title":"Clin Cancer Res"},{"key":"BFonc2009181_CR45","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher VG, Tibshirani R, Chu G . (2001). Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116\u20135121.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009181_CR46","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1016\/S0002-9440(10)64286-1","volume":"162","author":"GJ van Leenders","year":"2003","unstructured":"van Leenders GJ, Gage WR, Hicks JL, van Balken B, Aalders TW, Schalken JA et al. (2003). Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol 162: 1529\u20131537.","journal-title":"Am J Pathol"},{"key":"BFonc2009181_CR47","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","volume":"4","author":"S Wang","year":"2003","unstructured":"Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J et al. (2003). Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4: 209\u2013221.","journal-title":"Cancer Cell"},{"key":"BFonc2009181_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0925-4773(00)00551-7","volume":"101","author":"X Wu","year":"2001","unstructured":"Wu X, Wu J, Huang J, Powell WC, Zhang J, Matusik RJ et al. (2001). Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev 101: 61\u201369.","journal-title":"Mech Dev"},{"key":"BFonc2009181_CR49","doi-asserted-by":"publisher","first-page":"6942","DOI":"10.1073\/pnas.0502320102","volume":"102","author":"L Xin","year":"2005","unstructured":"Xin L, Lawson DA, Witte ON . (2005). The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102: 6942\u20136947.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFonc2009181_CR50","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1158\/0008-5472.CAN-05-1550","volume":"66","author":"SL Zheng","year":"2006","unstructured":"Zheng SL, Ju JH, Chang BL, Ortner E, Sun J, Isaacs SD et al. (2006). Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Cancer Res 66: 69\u201377.","journal-title":"Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/onc2009181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009181","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/onc2009181.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T16:24:07Z","timestamp":1647879847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/onc2009181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,13]]},"references-count":50,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2009,9,17]]}},"alternative-id":["BFonc2009181"],"URL":"https:\/\/doi.org\/10.1038\/onc.2009.181","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,7,13]]},"assertion":[{"value":"25 November 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2009","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2009","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2009","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}